You are here

Therapeutic Advances in Drug Safety

Therapeutic Advances in Drug Safety

eISSN: 20420994 | ISSN: 20420986 | Current volume: 14 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Launched in 2010.
  • Gold open access journal – all articles are made freely available online immediately upon publication.
  • Rigorous peer review.
  • Listed in PubMed and indexed in Clarivate Analytics: Science Citation Index Expanded (SCIE), Scopus, and International Pharmaceutical Abstracts (ProQuest).
  • Over 220,000 full article views annually.

Therapeutic Advances in Drug Safety is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of drug safety. Please see the Aims and Scope tab for further information.

The journal is a member of the Committee on Publication Ethics (COPE).

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Drug Safety (TADS) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the drug safety community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Open access information

The article processing charge (APC) for this journal is currently USD 2800. The APC for a Plain Language Summary is $4500.

The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Please direct any enquiries to

This journal changed its publication mode from subscription to open access in 2019.

Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The journal is dedicated to publishing clinical research, including qualitative studies. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion pieces, perspective reviews (including single-drug and drug class reviews), patient perspectives, narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.

Arduino Mangoni MD, MRCP (UK), FRACP, FRCP (London), FRCP (Glasgow), FRCP (Edinburgh) Flinders Medical Centre and Flinders University, Bedford Park, Australia
Managing Editor
Shasha Sharief SAGE Publishing, London, UK
Shikha Tomar SAGE Publishing, India
Associate Editors
Joris Berwaerts MD J&J Pharmaceutical Research & Development, USA
Matthew P. Doogue BSc, MBCHB, DipPaed, FRACP Univeristy of Otago Christchurch, New Zealand
Debabrata Roy, PhD Drug Safety Research Unit, Southampton, UK
Roy Soiza MB, ChB. MRCP NHS Grampian, Aberdeen, UK
Stephen Waring BMedSci, MB, BCh, BAO, PhD York Hospitals NHS Trust, UK
Biostatistical Editors
Royes Joseph, PhD School of Medicine, Keele University, UK
Chang-Xing Ma, PhD Department of Biostatistics, University at Buffalo, New York, USA
Mandy Michelle McBroom MPH UT Southwestern Medical Center, USA
Yoshihiro Noguchi, PhD Gifu Pharmaceutical University, Japan
Peer Review Assistant
Shikha Sapkota SAGE Publishing, India
Social Media Editor
Sara Tommasi, PhD Flinders University, Adelaide, Australia
Editorial Board
Anna Birna Almarsdóttir PdD, MS, MSc University of Copenhagen, Copenhagen, Denmark
Christopher Beer MB, BS, GradCertHPEd, PhD, FRACP Royal Perth Hospital, Perth, WA, Australia
J Simon Bell PhD Monash University, Melbourne, Australia
Phil Berry MBBS, Mphil Independent Pharmaceutical Consultant, Geneva, Switzerland
Carlos-Alberto Calderon-Ospina MD, PhD, MSc Pharmacology Unit, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia
Kin-Wei Chan MD, ScD, FISPE National Taiwan University, Taipei, Taiwan
Antonio Cherubini MD, PhD IRCCS INRCA, Ancona, Italy
Bernard Cheung MA, MB BChir, PhD, MRCP, FRCP, FCP, FHKCP, FHKAM (Medicine) The University of Hong Kong, Hong Kong
Claire Davies Medicines and Healthcare Products Regulatory Agency, London, UK
Alex Dodoo B.Pharm, MSc, PhD, FPSGH, FPCPharm University of Ghana Medical School, Accra, Ghana
Phil Hannaford MBChB University of Aberdeen, Aberdeen, UK
Manfred Hauben MD, PhD New York, NY, USA
Sarah Hilmer BScMed, MBBS, FRACP, PhD Royal North Shore Hospital, St Leonards, NSW, Australia
Paul Jansen MD, PhD University Medical Centre, Utrecht, Netherlands
Jimmy Jose MPharm, PhD School of Pharmacy, University of Nizwa, Oman
Neil Kaplowitz MD University of Southern California, Los Angeles, CA, USA
Star Khoza, PhD University of the Western Cape, South Africa
Stephen Leslie BSc, MB ChB, PhD, FRCP Raigmore Hospital, Inverness, UK
Sunny Linnebur Pharm.D, FCCO, BCPS, CGP Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Denver, Colorado, USA
Mary J Macleod BSc, MBChB, PhD, FRCP University of Aberdeen, Aberdeen, UK
Jennifer Martin MA, MBBS, PhD University of Queensland, Brisbane, QLD, Australia
Glenn Matfin MB, ChB National Health Service, London, UK
Patricia Mcgettigan MD, FRCPI, FRACP Hull York Medical School, Hull/York, UK
Christoph Meier PhD, MSc University Hospital Basel, Basel, Switzerland
Tadele Mekuriya Yadesa, B.Pharm, MSc, Ph.D Kampala International University, Uganda
Yola Moride PhD, FISPE Rutgers University, New Jersey, USA
Vicky Parikh MD, PPH Mid-Atlantic Medical Research Centers, Hollywood, MD, USA
Emilio Perucca University of Pavia, Pavia, Italy
Philip Pierce MD Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ, USA
Munir Pirmohamed BChB, MRCO, PhD, FRCP, FBPharmacolS University of Liverpool, Liverpool, UK
Thomas M. Polasek BSc, BPharm, PhD Flinders University, Adelaide, SA, Australia
Elena Ramírez, PhD, MD Autonomous University of Madrid, Spain
Amrit Ray MD, MBA Johnson & Johnson Pharmaceuticals Group, Titusville, NJ, USA
Michael Rieder MD, PhD Childrens Hospital of W. Ontario, London, ON, Canada
Luis Rios-Nogales MD, PhD Rational Vaccines, Boston, MA, USA
Greg Roberts Bpharm Repatriation General Hospital, Daw Park, SA, Australia
Allen Root University of South Florida, USA
Andrew Rowland Flinders University, Australia
Leo Russo MS, PhD Shire Pharmaceuticals, Wayne, PA, USA
Mohammed Salahudeen BPharm, PharmD, MBA, PhD, AFHEA School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Australia
Marco Sardella, PharmD, EEA QPPV ADIENNE Pharma & Biotech, Monza e Brianza, Italy
Carmelo Scarpignato MD, DSc, FRCP, FACP, FACG University of Parma, Parma, Italy
Rashmi Shah BSc, MBBS, FRCP, FRCP, MD, FFPM, HonFBPhS Rashmi Shah Consultancy Ltd, Gerrards Cross, UK
Michael Sorich Flinders University, Australia
Scott Twaddell BMedSc, BMed, GCClinTox, FRACP University of Newcastle, Newcastle, NSW, Australia
Allen Vaida PharmD, BSc Institute of Safe Medication Practices, Horsham, PA, USA
Tjeerd Van Staa MD, PhD, MA, MSc Medicines and Healthcare Products Regulatory Agency, London, UK
David Williams PhD, FRCP Royal College of Surgeons, Eire, Ireland
Richard Woodman PhD, MBiostats, MMedSco, BSc Flinders Centre for Epidemiology and Biostatistics, Flinders University, Adelaide, Australia
Jane Woolley PhD Medicines and Healthcare products Regulatory Agency, USA
Jian Zhang, PhD Zhujiang Hospital of Southern Medical University, China
Patient Advisory Board
Tina Aswani Omprakash Patient Advocate
Trishna Bharadia Patient Advocate, Maidenhead, UK
Anisha Gangotra Patient Advocate, High Wycombe, UK
Dominique Hamerlijnck MPhil, MBA European Patients' Academy (EUPATI), Amsterdam, Netherlands
Sheila Khawaja The World Alliance of Pituitary Organizations (WAPO), Monfalcone, Italy
Paola Kruger European Patients' Academy (EUPATI), Rome, Italy
Rising Stars in Drug Safety
Oisín Kavanagh, MPharm, MPSI, MPSNI, PhD Newcastle University, United Kingdom
Olivia Lounsbury, BS Johns Hopkins Hospital, Baltimore, MD, USA
Sule Ajibola Saka, BPharm; MPharm; PhD, UKZN Faculty of Pharmacy, Olabisi Onabanjo University, Agoiwoye, Nigeria
Vasileios-Periklis Stamatellos, MD, MSc Aristotle University of Thessaloniki, Department of Clinical Pharmacology, Greece
Editorial Review Board
Tesfay Mehari Atey, PhD, MBA, MSc, BPharm Department of Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Mekelle University School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania
Kimberly L. Barefield, PharmD, MHA, CDCES, BCPS Philadelphia College of Osteopathic Medicine, Georgia, USA
Jaden Brandt, BSc.Pharm, MSc, DipPH University of Manitoba, Manitoba, Canada
Jaqueline Eserian, PhD Adolfo Lutz Institute, São Paulo, Brazil
Jennifer Ilomaki, Msc, MD Centre for Medicine Use and Safety, Monash University, Australia
Noami Jessurun, PharmD, PhD Pharmacovigilance Centre Lareb, The Netherlands
Mahmathi Karuppannan, BPharm (Hons.), MPharm, Ph.D Universiti Teknologi MARA, Shah Alam Selangor, Malaysia
Ronald Kiguba, BPharm, MSc, PhD Makerere University College of Health Sciences, Uganda
Samantha Lane, MSc Drug Safety Research Unit, Southampton, UK
Syed Arman Rabbani, PhD RAK Medical & Health Sciences University, UAE
Daniela A. Rodrigues, MSc Research Laboratory on Epidemiology and Population Health, Polytechnic of Guarda, Portugal
Maha Saad, PharmD, BCGP, BCPS St. John's University College of Pharmacy and Health Sciences, UK
Carrie Stewart, PhD Institute of Applied Health Sciences, University of Aberdeen, Scotland
Selvarani Subbarayan, MBBS, MSc., PhD Novabiotics, UK
Mojtaba Vaismoradi, Prof., PhD, MScN, BScN Nord University, Bodø, Norway
Chen-Yu Wang, PhD National Center for Geriatric and Welfare Research, National Health Research Institutes, Miaoli County, Taiwan
Nadir Yalcin, PhD Hacettepe University, Ankara, Turkey
  • Clarivate Analytics: Current Contents - Clinical Medicine
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.